PubMed:19759529 / 463-681 JSONTXT

{"project":"LitCoin-sentences","denotations":[{"id":"T4","span":{"begin":0,"end":218},"obj":"Sentence"}],"text":"As a result, there is a growing interest in the development of pharmacological agents with potential antipsychotic properties that enhance the activity of the glutamatergic system via a modulation of the NMDA receptor."}

{"project":"LitCoin-entities","denotations":[{"id":"6456","span":{"begin":204,"end":217},"obj":"GeneOrGeneProduct"}],"attributes":[{"id":"A10","pred":"db_id","subj":"6456","obj":"NCBIGene:14810"}],"namespaces":[{"prefix":"_base","uri":"https://w3id.org/biolink/vocab/"},{"prefix":"MESH","uri":"http://id.nlm.nih.gov/mesh/"},{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id="},{"prefix":"NCBIGene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"OMIM","uri":"https://www.omim.org/entry/"},{"prefix":"DBSNP","uri":"https://www.ncbi.nlm.nih.gov/snp/"}],"text":"As a result, there is a growing interest in the development of pharmacological agents with potential antipsychotic properties that enhance the activity of the glutamatergic system via a modulation of the NMDA receptor."}

{"project":"LitCoin-GeneOrGeneProduct-v0","denotations":[{"id":"T13","span":{"begin":24,"end":31},"obj":"GeneOrGeneProduct"},{"id":"T14","span":{"begin":143,"end":151},"obj":"GeneOrGeneProduct"},{"id":"T15","span":{"begin":180,"end":185},"obj":"GeneOrGeneProduct"},{"id":"T16","span":{"begin":204,"end":217},"obj":"GeneOrGeneProduct"}],"text":"As a result, there is a growing interest in the development of pharmacological agents with potential antipsychotic properties that enhance the activity of the glutamatergic system via a modulation of the NMDA receptor."}

{"project":"LitCoin-GeneOrGeneProduct-v2","denotations":[{"id":"T11","span":{"begin":204,"end":217},"obj":"GeneOrGeneProduct"}],"text":"As a result, there is a growing interest in the development of pharmacological agents with potential antipsychotic properties that enhance the activity of the glutamatergic system via a modulation of the NMDA receptor."}

{"project":"LitCoin-GeneOrGeneProduct-v3","denotations":[{"id":"T6","span":{"begin":204,"end":217},"obj":"GeneOrGeneProduct"}],"text":"As a result, there is a growing interest in the development of pharmacological agents with potential antipsychotic properties that enhance the activity of the glutamatergic system via a modulation of the NMDA receptor."}

{"project":"LitCoin-Chemical-MeSH-CHEBI","denotations":[{"id":"T15","span":{"begin":204,"end":208},"obj":"ChemicalEntity"}],"attributes":[{"id":"A15","pred":"ID:","subj":"T15","obj":"http://purl.obolibrary.org/obo/CHEBI_6121"},{"id":"A16","pred":"ID:","subj":"T15","obj":"http://purl.obolibrary.org/obo/CHEBI_31882"}],"text":"As a result, there is a growing interest in the development of pharmacological agents with potential antipsychotic properties that enhance the activity of the glutamatergic system via a modulation of the NMDA receptor."}

{"project":"LitCoin-training-merged","denotations":[{"id":"T15","span":{"begin":204,"end":208},"obj":"ChemicalEntity"},{"id":"T6","span":{"begin":204,"end":217},"obj":"GeneOrGeneProduct"}],"attributes":[{"id":"A16","pred":"ID:","subj":"T15","obj":"http://purl.obolibrary.org/obo/CHEBI_31882"},{"id":"A15","pred":"ID:","subj":"T15","obj":"http://purl.obolibrary.org/obo/CHEBI_6121"}],"text":"As a result, there is a growing interest in the development of pharmacological agents with potential antipsychotic properties that enhance the activity of the glutamatergic system via a modulation of the NMDA receptor."}